Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Microdose LSD trial targets monthly mood swings

NCT ID NCT07189299

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times

Summary

This study tests whether very low doses of LSD can reduce the emotional and physical symptoms of premenstrual disorders like PMS and PMDD. 150 women will receive either LSD or a placebo during the late luteal phase of their cycle for three months. The goal is to see if this approach safely eases symptom burden.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical Pharmacology & Toxicology, University Hospital Basel

    Basel, Canton of Basel-City, 4056, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.